In cooperation with the Department for Dermatology, Allergy and Venereology of the Hannover Medical School (MHH), Fraunhofer ITEM has recently started a phase-I study to test the safety, tolerability, and efficacy of a novel monoclonal antibody in patients with allergic asthma or atopic dermatitis. The infrastructure of the CRC Hannover perfectly meets the requirements of this study with regard to multiple overnight stays and intensive monitoring of the test subjects. The Fraunhofer ITEM team is coordinating this project, will perform the phase-I examinations on site and identify suitable patients with allergic asthma. Identification of suitable patients with atopic dermatitis and performance of special dermatological procedures in this study will be performed by Professor Werfel and his MHH team.
Dr. med. Philipp Badorrek
+49 511 5950-8130